T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Fortinet
FTNT
|
+$2.09B |
| 2 |
Rockwell Automation
ROK
|
+$1.46B |
| 3 |
Autodesk
ADSK
|
+$1.19B |
| 4 |
Citigroup
C
|
+$1.11B |
| 5 |
ConocoPhillips
COP
|
+$1.08B |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$3.23B |
| 2 |
GE Aerospace
GE
|
+$2.12B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$1.46B |
| 4 |
Meta Platforms (Facebook)
META
|
+$1.17B |
| 5 |
Philip Morris
PM
|
+$1.06B |
Sector Composition
| 1 | Technology | 32.25% |
| 2 | Healthcare | 15.42% |
| 3 | Financials | 10.99% |
| 4 | Consumer Discretionary | 10.37% |
| 5 | Communication Services | 8.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2676
Aldeyra Therapeutics
ALDX
$346M
| $158K | ﹤0.01% |
48,273
+3,446
| +8% | +$11.3K |
|
2677
Altimmune
ALT
$334M
| $156K | ﹤0.01% |
15,238
+1,821
| +14% | +$18.6K |
|
2678
Costamare
CMRE
$1.48B
| $156K | ﹤0.01% |
13,681
+2,223
| +19% | +$25.3K |
|
|
FNA
2679
DELISTED
Paragon 28, Inc.
FNA
| $156K | ﹤0.01% |
12,622
+1,766
| +16% | +$21.8K |
|
|
TSVT
2680
DELISTED
2seventy bio
TSVT
| $155K | ﹤0.01% |
28,929
+2,893
| +11% | +$15.5K |
|
2681
Stereotaxis
STXS
$263M
| $153K | ﹤0.01% |
58,400
| – | – |
|
|
VINC
2682
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
| $152K | ﹤0.01% |
1,500
-500
| -25% | -$50.7K |
|
2683
Fulcrum Therapeutics
FULC
$392M
| $151K | ﹤0.01% |
15,900
| – | – |
|
2684
Navitas Semiconductor
NVTS
$1.23B
| $151K | ﹤0.01% |
31,646
+4,533
| +17% | +$21.6K |
|
|
KG
2685
Kestrel Group, Ltd.
KG
$195M
| $150K | ﹤0.01% |
3,323
+333
| +11% | +$15K |
|
|
SELF
2686
Global Self Storage
SELF
$58.3M
| $149K | ﹤0.01% |
33,399
| – | – |
|
2687
Evolv Technologies
EVLV
$1.44B
| $147K | ﹤0.01% |
32,813
+5,062
| +18% | +$22.7K |
|
2688
Heritage Commerce
HTBK
$629M
| $146K | ﹤0.01% |
16,966
+2,159
| +15% | +$18.6K |
|
2689
OmniAb
OABI
$226M
| $146K | ﹤0.01% |
26,843
+3,108
| +13% | +$16.9K |
|
2690
Lands' End
LE
$432M
| $145K | ﹤0.01% |
13,264
+237
| +2% | +$2.59K |
|
2691
Organogenesis Holdings
ORGO
$620M
| $145K | ﹤0.01% |
50,951
+5,359
| +12% | +$15.3K |
|
2692
Karyopharm Therapeutics
KPTI
$54.9M
| $144K | ﹤0.01% |
6,339
+531
| +9% | +$12.1K |
|
2693
XBiotech
XBIT
$85.1M
| $144K | ﹤0.01% |
17,600
| – | – |
|
2694
Alpha Pro Tech
APT
$50.8M
| $143K | ﹤0.01% |
22,900
| – | – |
|
|
FPI
2695
Farmland Partners
FPI
$473M
| $143K | ﹤0.01% |
12,855
+1,286
| +11% | +$14.3K |
|
2696
SmartRent
SMRT
$275M
| $143K | ﹤0.01% |
53,177
+8,169
| +18% | +$22K |
|
2697
Personalis
PSNL
$478M
| $142K | ﹤0.01% |
95,000
+34,900
| +58% | +$52.2K |
|
2698
Unisys
UIS
$279M
| $142K | ﹤0.01% |
28,861
-15,206
| -35% | -$74.8K |
|
|
NAPA
2699
DELISTED
The Duckhorn Portfolio, Inc.
NAPA
| $142K | ﹤0.01% |
15,216
+4,170
| +38% | +$38.9K |
|
|
TWOU
2700
DELISTED
2U, Inc.
TWOU
| $141K | ﹤0.01% |
12,058
+8,427
| +232% | +$98.5K |
|